Biotoxtech Co., Ltd. (KOSDAQ:086040)

South Korea · Delayed Price · Currency is KRW

2,380.00

+45.00 (1.93%)

At close: Aug 24, 2026

Biotoxtech Financials Overview

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	47,636	47,017	41,341	32,631	37,292	32,717
Revenue Growth	9.26%	13.73%	26.69%	-12.50%	13.98%	23.79%
Gross Profit	5,574	5,802	2,499	1,862	12,429	10,509
Operating Income	-6,310	-5,908	-8,619	-8,676	800.05	4,632
Net Income	769.13	1,163	-6,427	-4,878	2,725	7,114
Earnings Per Share	49.48	74.43	-405.00	-316.14	185.86	444.28
EPS Growth	-	-	-	-	-58.17%	148.20%

Cash & Debt

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Investments	25,520	28,132	32,384	41,038	30,771	28,151
Total Debt	62,192	62,500	63,049	61,591	49,140	27,049
Net Cash (Debt)	-36,673	-34,367	-30,665	-20,553	-18,369	1,102
Net Cash Growth	-	-	-	-	-	-71.82%
Net Cash Per Share	-2359.19	-2199.82	-1932.30	-1332.10	-1255.03	71.58

Cash Flow & CapEx

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Operating Cash Flow	6,640	6,636	-7,120	-16,238	-1,309	4,346
Capital Expenditures	-3,073	-2,121	-1,977	-4,452	-30,676	-7,619
Free Cash Flow	3,567	4,515	-9,097	-20,691	-31,985	-3,273
Free Cash Flow Growth	-	-	-	-	-	-

Margins

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Gross Margin	11.70%	12.34%	6.04%	5.71%	33.33%	32.12%
Operating Margin	-13.25%	-12.57%	-20.85%	-26.59%	2.15%	14.16%
Pretax Margin	-1.86%	-0.74%	-21.34%	-36.26%	-1.73%	19.82%
Profit Margin	1.62%	2.47%	-15.55%	-14.95%	7.31%	21.74%
FCF Margin	7.49%	9.60%	-22.00%	-63.41%	-85.77%	-10.00%

Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug '26 Aug 24, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
PE Ratio	48.10	38.06	-	-	43.72	16.50
Forward PE	-	25.30	25.30	25.30	25.30	25.30
P/FCF Ratio	10.49	9.80	-	-	-	-
PS Ratio	0.79	0.94	1.27	3.01	3.20	3.59